Revenue · 2011–2025
Acadia Pharmaceuticals revenue
$1.1B+11.9% · FY2025
Acadia Pharmaceuticals (ACAD) reported $1.1B in revenue for fiscal 2025, +11.9% year on year.
| Fiscal year | Revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $1.1B | +11.9% | Open → |
| FY20242024-12-31 | $958M | +31.8% | Open → |
| FY20232023-12-31 | $726M | +40.4% | Open → |
| FY20222022-12-31 | $517M | +6.8% | Open → |
| FY20212021-12-31 | $484M | +9.6% | Open → |
| FY20202020-12-31 | $442M | +30.3% | Open → |
| FY20192019-12-31 | $339M | +51.5% | Open → |
| FY20182018-12-31 | $224M | +79.2% | Open → |
| FY20172017-12-31 | $125M | +620.7% | Open → |
| FY20162016-12-31 | $17.3M | +28,311.5% | Open → |
| FY20152015-12-31 | $61,000 | −49.2% | Open → |
| FY20142014-12-31 | $120,000 | −89.5% | Open → |
| FY20132013-12-31 | $1.1M | −76.7% | Open → |
| FY20122012-12-31 | $4.9M | +137.4% | Open → |
| FY20112011-12-31 | $2.1M | — | Open → |
Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +56.3%
Revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Acadia Pharmaceuticals revenue |url=https://companiesranked.com/en/company/acadia-pharmaceuticals/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Acadia Pharmaceuticals revenue. CompaniesRanked. https://companiesranked.com/en/company/acadia-pharmaceuticals/revenueBibTeX
@misc{companiesranked-en-company-acadia-pharmaceuticals-revenue-2026,
author = {{CompaniesRanked}},
title = {{Acadia Pharmaceuticals revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/acadia-pharmaceuticals/revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001193125-26-072519 · February 26, 2026
{{cite web |title=Acadia Pharmaceuticals revenue — 10-K (0001193125-26-072519) |url=https://www.sec.gov/Archives/edgar/data/1070494/000119312526072519/acad-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.